• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

GAO Push for Lower Dialysis Bundle Spurs Controversy

Article

Dialysis and kidney-care providers are taking issue with a Government Accountability Office report released this month that found the government may be over-paying for end-stage renal disease treatment.

The report called on the CMS to re-examine the amount it's paying (PDF) for dialysis care, arguing that the agency bases its bundled payment rates on 5-year-old drug utilization trends that are no longer current.

It added that if the payments accurately reflected current prescribing trends for end-stage renal disease, Medicare would have saved at least $650 million in 2011, up to as much as $880 million—and that those savings are only forecasted to grow.

Read the full story: http://bit.ly/12xSDjv

Source: ModernHealthcare.com

Related Videos
Kimberly Westrich, MA, chief strategy officer, National Pharmaceutical Council
Chicago skyline with words "CHEST 2025 Recap Chicago, Illinois" | Image credit: SeanPavonePhoto - stock.adobe.com
Dr Brian Mulherin
Dr Brian Mulherin
Lindsey Valenzuela, PharmD, APh, BCACP - screenshot by AJMC
Robert Andrews, former US representative for New Jersey and CEO of the Health Transformation Alliance
Robert Andrews, chief executive officer, Health Transformation Alliance
Dr David Kuter
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.